SUTENT® In The First Line Treatment Of Renal Cell Carcinoma

NCT00460798 · clinicaltrials.gov ↗
COMPLETED
Status
356
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer